The sales are small relative to market cap and executed under 10b5-1 plans, so no bearish signal. Monitor for any unplanned insider selling in the coming weeks that would break the pattern.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $105.81entry
- T+1 · 5d ago −0.01%α +0.34% · $105.80
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Two Edwards Lifesciences insiders, including the CEO, executed open-market sales totaling $5.99M under 10b5-1 plans six days after the company reported a Q3 2026 earnings beat and raised guidance. The sales represent approximately 0.01% of market cap, which is trivial relative to the company's $58.7B market cap, and are consistent with routine pre-planned diversification.
Key Financial Metrics
Key Facts
- CEO Bernard Zovighian sold 23,100 shares total ($2.38M) on 2026-11-09 under a 10b5-1 plan
- CVP Donald Bobo sold 48,900 shares ($5.04M) on 2026-11-09 under a 10b5-1 plan
- Total open-market sales: $5.99M, representing ~0.01% of $58.7B market cap
- Sales occurred 6 days after Q3 2026 earnings beat (EPS $0.80 vs $0.74 consensus) and raised guidance
- Both sales were under 10b5-1 plans, indicating pre-planned transactions
Financial Impact
Total insider sales of $5.99M, or 0.01% of market cap
Risk Factors
- Insider sales under 10b5-1 plans are routine and not indicative of negative outlook
- No material risk identified from this cluster
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EW-1794347565039 |
Track record
27 reports on EW
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +4.94% at T+5 after the Nov 4, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Viewing Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $105.81 Now $107.11 +1.23% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $104.01 Now $107.11 +2.98% settles Nov 17
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $100.82 to $105.80 Now $107.11 +6.24% ▲ +4.94% +1.65% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $94.44 to $100.82 Now $107.11 +13.42% ▲ +6.76% +11.48% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $90.74 to $86.18 Now $107.11 +18.04% ▼ −5.03% −5.11% vs SPY
- Aug 28, 202611w ago Insider Cluster Neutral 2/10 Entry $90.75 to $86.72 Now $107.11 +18.03% ▼ −4.44% −4.30% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers